Byvalson Side Effects
Generic name: nebivolol / valsartan
Medically reviewed by Drugs.com. Last updated on Sep 1, 2024.
Note: This document provides detailed information about Byvalson Side Effects associated with nebivolol / valsartan. Some dosage forms listed on this page may not apply specifically to the brand name Byvalson.
Applies to nebivolol / valsartan: oral tablet.
Important warnings
This medicine can cause some serious health issues
Serious side effects of Byvalson
Along with its needed effects, nebivolol / valsartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking nebivolol / valsartan:
Incidence not known
- blurred vision
- chest pain or tightness
- confusion
- decreased urine output
- difficult breathing
- dilated neck veins
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- extreme fatigue
- irregular breathing
- irregular heartbeat
- nausea or vomiting
- nervousness
- numbness or tingling in the hands, feet, or lips
- stomach pain
- sweating
- swelling of the face, fingers, feet, or lower legs
- trouble breathing
- unusual tiredness or weakness
- weakness or heaviness of the legs
- weight gain
For healthcare professionals
Applies to nebivolol / valsartan: oral tablet.
Cardiovascular adverse events
- Frequency not reported: Hypotension
Nebivolol:
- Postmarketing reports: Atrioventricular block (both second and third degree), myocardial infarction, Raynaud's phenomenon, peripheral ischemia/claudication
Valsartan:
- Postmarketing reports: Vasculitis[Ref]
Dermatologic
- Rare (0.01% to 0.1%): Angioedema
Nebivolol:
- Postmarketing reports: Pruritus, psoriasis, various rashes, various skin disorders, urticaria, allergic vasculitis
Valsartan:
- Postmarketing reports: Angioedema, alopecia, bullous dermatitis[Ref]
Gastrointestinal
- Postmarketing reports: Vomiting[Ref]
Genitourinary
- Postmarketing reports: Erectile dysfunction
Nebivolol:
- Postmarketing reports: Thrombocytopenia
Valsartan:
- Postmarketing reports: Thrombocytopenia[Ref]
Hepatic
Nebivolol:
- Postmarketing reports: Abnormal hepatic function (including increased AST, ALT, and bilirubin)
Valsartan:
- Postmarketing reports: Elevated liver enzymes, hepatitis
Valsartan:
- Postmarketing reports: Angioedema[Ref]
Metabolic
- Common (1% to 10%): Hyperkalemia
Valsartan:
- Postmarketing reports: Hyperkalemia[Ref]
Nervous system
Nebivolol:
- Postmarketing reports: Acute renal failure
Valsartan:
- Postmarketing reports: Impaired renal function, renal failure[Ref]
Respiratory
Nebivolol:
- Postmarketing reports: Acute pulmonary edema, bronchospasm[Ref]
References
1. (2016) "Product Information. Byvalson (nebivolol-valsartan)." Actavis Pharma, Inc.
Frequently asked questions
More about Byvalson (nebivolol / valsartan)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihypertensive combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Byvalson side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.